Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
14.72
-0.71 (-4.60%)
At close: Aug 11, 2026, 4:00 PM EDT
14.75
+0.03 (0.20%)
After-hours: Aug 11, 2026, 7:53 PM EDT
Silence Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Silence Therapeutics stock has a consensus rating of "Buy" and an average price target of $35.6. The average 1-year stock price forecast is 141.85% higher than the current stock price, while the lowest is $19 (+29.08%) and the highest is $75 (+409.51%).
Price Target: $35.6 (+141.85%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Silence Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $25 → $32 | Buy | Reiterates | $25 → $32 | +117.39% | Aug 11, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $27 | Buy | Maintains | $27 | +83.42% | Aug 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $75 | Buy | Reiterates | $75 | +409.51% | Aug 10, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 10, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $4 | Sell | Maintains | $4 | -72.83% | Jul 27, 2026 |
Financial Forecast
Revenue This Year
3.36M
from 559.00K
Increased by 500.81%
Revenue Next Year
4.63M
from 3.36M
Increased by 38.00%
EPS This Year
-0.37
EPS Next Year
4.79
from -0.37
EPS and Forward PE are based on non-GAAP adjusted numbers.